ArticleScientific reports2024

Ceftazidime-avibactam for the treatment of febrile neutropenia in HSCT recipients and acute leukemia patients post induction chemotherapy.

Jim Abi Frem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.